AAAAAA

   
Results: 1-2 |
Results: 2
MINIMUM EFFECTIVE DOSE AND DURATION TO REVERSE NEUTROPENIA IN NONCANCER PATIENTS WITH ADVANCED HIV DISEASE
Authors: HERMANS P FRANCHIOLY P THIOUX C GRAY SJ VANNEROM H CLUMECK N
Citation: P. Hermans et al., MINIMUM EFFECTIVE DOSE AND DURATION TO REVERSE NEUTROPENIA IN NONCANCER PATIENTS WITH ADVANCED HIV DISEASE, AIDS, 10(9), 1996, pp. 1050-1051
A RANDOMIZED PILOT CLINICAL-TRIAL COMPARING 5 VERSUS 10 MU-G KG FILGRASTIM (NEUPOGEN) AFTER FEC CHEMOTHERAPY IN ORDER TO COLLECT PERIPHERAL-BLOOD STEM-CELLS (PBSC)/
Authors: DHONDT L ANDRE M GUILLAUME T FEYENS AM CANON JL DOYEN C HUMBLET Y LONGUEVILLE J VANNEROM H SYMANN M
Citation: L. Dhondt et al., A RANDOMIZED PILOT CLINICAL-TRIAL COMPARING 5 VERSUS 10 MU-G KG FILGRASTIM (NEUPOGEN) AFTER FEC CHEMOTHERAPY IN ORDER TO COLLECT PERIPHERAL-BLOOD STEM-CELLS (PBSC)/, European journal of cancer, 31A, 1995, pp. 355-355
Risultati: 1-2 |